Additionally, NDC-011, a novel drug combination developed through DR.NOAH's AI-based drug discovery platform, received Orphan Drug Designation (ODD) from the U.S. FDA in 2023 and IND approval for a ...
ALS is described as ‘freezing disease’ because it creates sensation of being trapped or ‘frozen’ within an immobile body as ...
The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...
PRESS RELEASE AB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV HIGHLIGHTING CLINICAL BENEFIT WITH MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS PRIOR ANY COMPLETE LOSS OF FUNCTION Significant ...
Gov. Kathy Hochul cast the measure in unusually personal terms, saying she had felt “the pain of seeing someone you love ...
Wave Life Sciences Ltd is a pioneering force in genetic medicine, focusing on creating innovative treatments for serious ...
PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s ...
Well known names from across showbiz, politics, business and sport died in 2025. Here we look back at some of those who left ...
A Northwestern Medicine study has shed light on a critical molecular mechanism underlying amyotrophic lateral sclerosis (ALS) ...
Neurology biotech Voyager Therapeutics has laid off 30 employees, a spokesperson for the Massachusetts-based company ...
Using machine learning models, researchers at Michigan Medicine have identified a potential way to diagnose amyotrophic lateral sclerosis, or ALS, earlier from a blood sample, a study suggests. They ...
The news comes eight months after Dane shared in an exclusive statement to PEOPLE that he has been diagnosed with amyotrophic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback